The company has market cap of $12.03 billion. It has a 16.76 P/E ratio. The firm offers therapeutic agents to treat cardiovascular, type 2 diabetes, asthma, nasal allergy symptoms, allergic rhinitis, chronic hepatitis C virus, HIV-1 infection, fungal and intra-abdominal infections, hypertension, arthritis and pain, inflammatory, osteoporosis, and fertility diseases.
Pekin Singer Strauss Asset Management increased its stake in Mckesson Corp (MCK) by 610.14% based on its latest 2017Q2 regulatory filing with the SEC. Commerce Bank sold 4,303 shares as Mckesson Corp (MCK)'s stock rose 1.84%. Ledyard Retail Bank owns 1,890 shares for 0.04% of their portfolio. The stock decreased 0.91% or $1.35 during the last trading session, reaching $146.39. The shares were sold at an average price of $151.67, for a total transaction of $34,125,750.00. The legal version of this story can be accessed at https://weekherald.com/2017/12/03/51-98-billion-in-sales-expected-for-mckesson-corporation-mck-this-quarter-2.html. It has underperformed by 32.15% the S&P500. Two research analysts have rated the stock with a sell rating, six have assigned a hold rating and eleven have issued a buy rating to the stock. Therefore 43% are positive. McKesson Corporation has a 1-year low of $133.82 and a 1-year high of $169.29. McKesson Corporation now has a consensus rating of "Hold" and a consensus price target of $174.27. McKesson Corporation had 70 analyst reports since July 31, 2015 according to SRatingsIntel. As per Friday, September 16, the company rating was downgraded by Goldman Sachs. On Wednesday, June 21 the stock rating was maintained by Jefferies with "Hold". Mizuho set a $168.00 price objective on McKesson Corporation and gave the company a "hold" rating in a research report on Tuesday, October 24th. RBC Capital Markets maintained it with "Outperform" rating and $190.0 target in Tuesday, January 12 report. As per Thursday, October 6, the company rating was initiated by UBS.
In other McKesson Corporation news, Chairman John H. Hammergren sold 225,000 shares of the business's stock in a transaction on Friday, September 22nd. On Thursday, November 9 the stock rating was maintained by Credit Suisse with "Sell". Robert W. Baird raised shares of McKesson from a "neutral" rating to an "outperform" rating and upped their price target for the company from $175.00 to $178.00 in a report on Tuesday, September 19th. The firm has "Buy" rating by Mizuho given on Wednesday, November 9. They expect $4.19 EPS, down 3.23% or $0.14 from last year's $4.33 per share. Kennedy Capital Management Incorporated owns 143,444 shares. Amgen Inc (NASDAQ:AMGN) was raised too.
Investors of record on Friday, December 1st will be issued a $0.34 dividend. Its down 0.02, from 0.97 in 2017Q1.
Sumitomo Mitsui Trust Holdings Inc. cut its holdings in shares of McKesson Corporation (NYSE:MCK) by 1.9% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission.
A number of institutional investors and hedge funds have recently made changes to their positions in the business. The Bloom Tree Partners Llc holds 232,463 shares with $38.25 million value, down from 282,802 last quarter. Gemmer Asset Management Limited Liability Com invested in 0.02% or 243 shares. Moreover, Diversified Company has 0.03% invested in McKesson Corporation (NYSE:MCK) for 2,378 shares. The Massachusetts-based Panagora Asset Mngmt has invested 0.69% in McKesson Corporation (NYSE:MCK). Bankshares Of The West invested 0.28% in McKesson Corporation (NYSE:MCK). Maltese Ltd Liability Corporation reported 55,000 shares stake. Raymond James & Assocs reported 18,478 shares. Advsrs Cap Ltd stated it has 0.18% of its portfolio in McKesson Corporation (NYSE:MCK). Lpl Fincl Limited Liability holds 17,713 shares. Chevy Chase Hldg owns 182,799 shares for 0.14% of their portfolio. During the same quarter in the prior year, the business earned $2.94 earnings per share. equities analysts expect that McKesson Corporation will post 12.16 EPS for the current year. The United Kingdom-based Trinity Street Asset Management Llp has invested 6.94% in the stock. Hl Fin Service Lc invested in 0.02% or 6,533 shares. Jefferies maintained McKesson Corporation (NYSE:MCK) rating on Tuesday, August 29. WHR's profit will be $301.10M for 9.99 P/E if the $4.19 EPS becomes a reality. 3,588 were reported by Cypress Group Inc.
Ratings analysis reveals 86% of Merck's analysts are positive. California Pub Employees Retirement Sys holds 7,952 shares. WHR was included in 3 notes of analysts from September 12, 2016. On Tuesday, October 24 the stock rating was maintained by Needham with "Buy". Pacific Crest upgraded the shares of FIVN in report on Friday, March 17 to "Overweight" rating. The stock of Merck & Co., Inc. The firm has "Neutral" rating by JP Morgan given on Thursday, January 5. The firm has "Buy" rating given on Friday, January 13 by Bryan Garnier & Cie. The stock decreased 1.47% or $0.36 during the last trading session, reaching $24.15. (NASDAQ:PEBK) has risen 46.92% since December 2, 2016 and is uptrending. It has outperformed by 0.16% the S&P500. Morgan Stanley accumulated 1.38M shares. Krensavage Asset Management Llc owns 382,434 shares or 7.44% of their USA portfolio. Moreover, Carroll Assoc has 0.01% invested in Peoples Bancorp of North Carolina, Inc. Independent Consultants reported 460 shares stake.
Analysts await Merck & Co., Inc. (NASDAQ:FIVN) to report earnings on February, 15.
(TGT) Shares Sold by Sumitomo Mitsui Trust Holdings Inc
Following the completion of the purchase, the director now owns 16,431 shares in the company, valued at approximately $901,404.66. Sigma Planning Corp increased its stake in Target Corp (TGT) by 36.15% based on its latest 2017Q2 regulatory filing with the SEC.